Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Application of an indoleamine 2,3-dioxygenase-expressing skin substitute improves scar formation in a fibrotic animal model.
Chavez-Munoz C, Hartwell R, Jalili RB, Carr M, Kilani RT, Jafarnejad SM, Rahmani-Neishabour E, Forouzandeh F, Boyce ST, Ghahary A.
J Invest Dermatol. 2012 May;132(5):1501-5. doi: 10.1038/jid.2011.467. Epub 2012 Feb 2. No abstract available.
Related citations
Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma.
Miyagaki T, Sugaya M, Suga H, Morimura S, Ohmatsu H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S.
J Invest Dermatol. 2012 Apr;132(4):1280-9. doi: 10.1038/jid.2011.470. Epub 2012 Feb 2.
Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma.
Ladstein RG, Bachmann IM, Straume O, Akslen LA.
J Invest Dermatol. 2012 Apr;132(4):1247-52. doi: 10.1038/jid.2011.464. Epub 2012 Feb 2.
A Mouse Model of Vitiligo with Focused Epidermal Depigmentation Requires IFN-γ for Autoreactive CD8(+) T-Cell Accumulation in the Skin.
Harris JE, Harris TH, Weninger W, Wherry EJ, Hunter CA, Turka LA.
J Invest Dermatol. 2012 Feb 2. doi: 10.1038/jid.2011.463. [Epub ahead of print]
IFN-α Enhances IL-22 Receptor Expression in Keratinocytes: A Possible Role in the Development of Psoriasis.
Tohyama M, Yang L, Hanakawa Y, Dai X, Shirakata Y, Sayama K.
J Invest Dermatol. 2012 Feb 2. doi: 10.1038/jid.2011.468. [Epub ahead of print] No abstract available.
Critical role of paxillin in aging of human skin.
Zheng Q, Chen S, Chen Y, Lyga J, Santhanam U.
J Invest Dermatol. 2012 Apr;132(4):1290-3. doi: 10.1038/jid.2011.456. Epub 2012 Feb 2. No abstract available.
It's all about position: the basal layer of human epidermis is particularly susceptible to different types of sunlight-induced DNA damage.
Halliday GM, Cadet J.
J Invest Dermatol. 2012 Feb;132(2):265-7. doi: 10.1038/jid.2011.281.
MEK'ing the most of p53 reactivation therapy in melanoma.
Lee JT, Herlyn M.
J Invest Dermatol. 2012 Feb;132(2):263-5. doi: 10.1038/jid.2011.362.
A new xenotransplantation model reveals tumor-initiating cells in cutaneous squamous cell carcinoma.
Glick A.
J Invest Dermatol. 2012 Feb;132(2):261-2. doi: 10.1038/jid.2011.327.
Interaction of the profilaggrin N-terminal domain with loricrin in human cultured keratinocytes and epidermis.
Yoneda K, Nakagawa T, Lawrence OT, Huard J, Demitsu T, Kubota Y, Presland RB.
J Invest Dermatol. 2012 Apr;132(4):1206-14. doi: 10.1038/jid.2011.460. Epub 2012 Jan 26.
Defining keratin protein function in skin epithelia: epidermolysis bullosa simplex and its aftermath.
Coulombe PA, Lee CH.
J Invest Dermatol. 2012 Mar;132(3 Pt 2):763-75. doi: 10.1038/jid.2011.450. Epub 2012 Jan 26. Review.
IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors.
Savinko T, Matikainen S, Saarialho-Kere U, Lehto M, Wang G, Lehtimäki S, Karisola P, Reunala T, Wolff H, Lauerma A, Alenius H.
J Invest Dermatol. 2012 May;132(5):1392-400. doi: 10.1038/jid.2011.446. Epub 2012 Jan 26.
A single intradermal injection of IFN-γ induces an inflammatory state in both non-lesional psoriatic and healthy skin.
Johnson-Huang LM, Suárez-Fariñas M, Pierson KC, Fuentes-Duculan J, Cueto I, Lentini T, Sullivan-Whalen M, Gilleaudeau P, Krueger JG, Haider AS, Lowes MA.
J Invest Dermatol. 2012 Apr;132(4):1177-87. doi: 10.1038/jid.2011.458. Epub 2012 Jan 26.
Old and new: recent innovations in vaccine biology and skin T cells.
Kupper TS.
J Invest Dermatol. 2012 Mar;132(3 Pt 2):829-34. doi: 10.1038/jid.2011.400. Epub 2012 Jan 12. Review.
Genetics and epigenetics of the skin meet deep sequence.
Cheng JB, Cho RJ.
J Invest Dermatol. 2012 Mar;132(3 Pt 2):923-32. doi: 10.1038/jid.2011.436. Epub 2012 Jan 12. Review.
Chronology of metastasis in cutaneous melanoma: growth rate model.
Tejera-Vaquerizo A, Nagore E, Meléndez JJ, López-Navarro N, Martorell-Calatayud A, Herrera-Acosta E, Traves V, Guillén C, Herrera-Ceballos E.
J Invest Dermatol. 2012 Apr;132(4):1215-21. doi: 10.1038/jid.2011.433. Epub 2012 Jan 5.
The epidermis as an adjuvant.
Gutowska-Owsiak D, Ogg GS.
J Invest Dermatol. 2012 Mar;132(3 Pt 2):940-8. doi: 10.1038/jid.2011.398. Epub 2012 Jan 5. Review.
Melanoma: new insights and new therapies.
Nikolaou VA, Stratigos AJ, Flaherty KT, Tsao H.
J Invest Dermatol. 2012 Mar;132(3 Pt 2):854-63. doi: 10.1038/jid.2011.421. Epub 2012 Jan 5. Review.
Skin barrier disruption: a requirement for allergen sensitization?
De Benedetto A, Kubo A, Beck LA.
J Invest Dermatol. 2012 Mar;132(3 Pt 2):949-63. doi: 10.1038/jid.2011.435. Epub 2012 Jan 5. Review.
Control of central and peripheral tolerance to melanocyte differentiation antigens by GILT.
Becker JC, Schrama D.
J Invest Dermatol. 2012 Jan;132(1):15-7. doi: 10.1038/jid.2011.361.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on